Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Balazs Halmos; Yuxia Jia; Joseph A. Bokar; Pingfu Fu; David J. Adelstein; Rosalyn Juergens; Mary Beth Rodal; Afshin Dowlati
A Phase i Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer
Cheng Ean Chee; Smitha Krishnamurthi; Charles J. Nock; Neal J. Meropol; Joseph Gibbons; PingFu Fu; Joseph Bokar; Lois Teston; Timothy O'Brien; Vinay Gudena; et al.
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas
Matthew M. Cooney; Charles Nock; Joseph Bokar; Smitha Krishnamurthi; Joseph Gibbons; Mary Beth Rodal; Anne Ness; Scot C. Remick; Robert Dreicer; Afshin Dowlati
Phase I trial of pomalidomide given for patients with advanced solid tumors
Joanna M. Brell; Smitha S. Krishnamurthi; Linda Rath; Joseph A. Bokar; Panayiotis Savvides; Joseph Gibbons; Matthew M. Cooney; Neal J. Meropol; Percy Ivy; Afshin Dowlati
Phase i trial of sunitinib and gemcitabine in patients with advanced solid tumors
Kristi Beatty; Christine Winkelman; Joseph A. Bokar; Polly Mazanec
Advances in oncology care: Targeted therapies
Kristi Beatty; Christine Winkelman; Joseph A Bokar; Polly Mazanec
Advances in oncology care: targeted therapies.
Huda Salman; Hillard M. Lazarus
Plerixafor for autologous CD34+ cell mobilization
Charles J. Nock; Joanna M. Brell; Joseph A. Bokar; Matthew M. Cooney; Brenda Cooper; Joseph Gibbons; Smitha Krishnamurthi; Sudhir Manda; Panayiotis Savvides; Scot C. Remick; et al.
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors
Brian I. Rini; Jorge A. Garcia; Matthew M. Cooney; Paul Elson; Allison Tyler; Kristi Beatty; Joseph Bokar; Percy Ivy; Helen X. Chen; Afshin Dowlati; et al.
Toxicity of sunitinib plus bevacizumab in renal cell carcinoma
Sharon L. Sanborn; Joseph Gibbons; Smitha Krishnamurthi; Joanna M. Brell; Afshin Dowlati; Joseph A. Bokar; Charles Nock; Nancy Horvath; Jacob Bako; Scot C. Remick; et al.
Phase i trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
Brian I. Rini; Jorge A. Garcia; Matthew M. Cooney; Paul Elson; Allison Tyler; Kristi Beatty; Joseph Bokar; Tarek Mekhail; R.M. Bukowski; G. Thomas Budd; et al.
A phase I study of sunitinib plus bevacizumab in advanced solid tumors
Colin J. Mooney; Govardhanan Nagaiah; Pingfu Fu; Jay K. Wasman; Matthew M. Cooney; Panos S. Savvides; Joseph A. Bokar; Afshin Dowlati; Ding Wang; Sanjiv S. Agarwala; et al.
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome
Sharon L. Sanborn; Matthew M. Cooney; Afshin Dowlati; Joanna M. Brell; Smitha Krishnamurthi; Joseph Gibbons; Joseph A. Bokar; Charles Nock; Anne Ness; Scot C. Remick
Phase I trial of docetaxel and thalidomide: A regimen based on metronomic therapeutic principles
Chris C. W. Chan; Alan Tan; Huda Salman
Colon cancer 15 years after ureterosigmoidostomy
Alan Tan; Mohammadbagher Ziari; Huda Salman; Wilman Ortega; Cherise Cortese
Spontaneous rupture of the spleen in the presentation of acute myeloid leukemia
Huda Salman; Alejandra Perez; Joseph A. Sparano; Howard Ratech; Abdissa Negassa; Una Hopkins; Gina Villani; Joachim Fuks; Peter H. Wiernik
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma
Mary J. Clancy; Mary Eileen Shambaugh; Candace S. Timpte; Joseph A. Bokar
Induction of sporulation in Saccharomyces cerevisiae leads to the formation of N6-methyladenosine in mRNA: A potential mechanism for the activity of the IME4 gene
Huda S. Salman; Katie Tanaka; Joseph A. Sparano
Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes
Huda S. Salman; Jacov Cynamon; Marci Jagust; Curtis Bakal; Alla Rozenblit; Ron Kaleya; Abdissa Negassa; Scott Wadler
Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver
X. Li; M.E. Shambaug; F.M. Rottman; J.A. Bokar
SR proteins ASF/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro